Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.

Andrei Tchirkov; Jean-Louis Couderc; Bernard Périssel; Carole Goumy; Aline Regnier; Nancy Uhrhammer; Pierre Verrelle; M. Berger

doi:10.1038/sj.leu.2404012

Journal articles

Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.

Andrei Tchirkov ^{1, 2, *} Jean-Louis Couderc ³ Bernard Périssel ² Carole Goumy ² Aline Regnier ⁴ Nancy Uhrhammer ¹ Pierre Verrelle ¹ M. Berger ⁵

* Corresponding author

1 UNICANCER/CJP - Centre Jean Perrin [Clermont-Ferrand]

2 Service de Cytogénétique Médicale

3 Interactions génétiques et cellulaires au cours de la différenciation

4 Service de Médecine Interne

5 Service d'Hématologie

Résumé : N.A

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Development Biology

Complete list of metadatas

https://www.hal.inserm.fr/inserm-00077396
Contributor : Jean-Louis Couderc <>
Submitted on : Tuesday, March 6, 2007 - 2:57:43 PM
Last modification on : Thursday, June 11, 2020 - 3:19:30 AM
Long-term archiving on: : Monday, April 5, 2010 - 9:52:32 PM

Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.

Files

Identifiers

Collections

Citation

Export

Metrics

495

733

Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.

Files

Identifiers

Collections

Citation

Export

Share

Metrics

495

733